Why is swift detection so important?

Designed to detect mutations in the HIV-1 virus that are associated with drug resistance, the ViroSeq HIV-1 Genotyping System is a molecular diagnostic test used by physicians as an aid in monitoring and treating HIV infection. Celera Diagnostics manufactures the ViroSeq system, which is distributed exclusively by a CAC Diagnostics supplier through a previously announced strategic alliance. The ViroSeq system for the ABI PRISM® 3100 Genetic Analyzer and the ABI PRISM® 377 DNA Sequencer is now available.

The ViroSeq system consists of an Applied Biosystems automated DNA sequencing instrument and Celera Diagnostics reagents that are used to identify key strains of the HIV-1 virus. The system targets specific regions of the viral genome associated with drug-resistant mutations.

Genotyping is a sequencing-based testing method routinely used by laboratories and clinicians to determine the genetic composition of the HIV virus. Applied Biosystems sequencing instruments are currently used for a majority of the more than 150,000 HIV genotyping tests performed in the United States each year.